Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Role of extracellular disulfide-bonded cysteines in the ligand binding function of the beta 2-adrenergic receptor.

Dohlman HG, Caron MG, DeBlasi A, Frielle T, Lefkowitz RJ.

Biochemistry. 1990 Mar 6;29(9):2335-42.

PMID:
2159799
2.

Identification and function of disulfide bridges in the extracellular domains of the angiotensin II type 2 receptor.

Heerding JN, Hines J, Fluharty SJ, Yee DK.

Biochemistry. 2001 Jul 27;40(28):8369-77.

PMID:
11444984
5.

Mutagenic analysis of platelet thromboxane receptor cysteines. Roles in ligand binding and receptor-effector coupling.

D'Angelo DD, Eubank JJ, Davis MG, Dorn GW 2nd.

J Biol Chem. 1996 Mar 15;271(11):6233-40.

7.
8.
9.

Extracellular cysteines of the corticotropin-releasing factor receptor are critical for ligand interaction.

Qi LJ, Leung AT, Xiong Y, Marx KA, Abou-Samra AB.

Biochemistry. 1997 Oct 14;36(41):12442-8.

PMID:
9376348
10.

Extracellular cysteines of CCR5 are required for chemokine binding, but dispensable for HIV-1 coreceptor activity.

Blanpain C, Lee B, Vakili J, Doranz BJ, Govaerts C, Migeotte I, Sharron M, Dupriez V, Vassart G, Doms RW, Parmentier M.

J Biol Chem. 1999 Jul 2;274(27):18902-8.

11.

Structural features required for ligand binding to the beta-adrenergic receptor.

Dixon RA, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, Strader CD.

EMBO J. 1987 Nov;6(11):3269-75.

14.
15.

Functional significance of cysteine residues in the delta opioid receptor studied by site-directed mutagenesis.

Ehrlich GK, Andria ML, Zheng X, Kieffer B, Gioannini TL, Hiller JM, Rosenkranz JE, Veksler BM, Zukin RS, Simon EJ.

Can J Physiol Pharmacol. 1998 Mar;76(3):269-77.

PMID:
9673790
16.
17.

Mutation of human mu opioid receptor extracellular "disulfide cysteine" residues alters ligand binding but does not prevent receptor targeting to the cell plasma membrane.

Zhang P, Johnson PS, Zöllner C, Wang W, Wang Z, Montes AE, Seidleck BK, Blaschak CJ, Surratt CK.

Brain Res Mol Brain Res. 1999 Oct 1;72(2):195-204.

PMID:
10529478
18.
19.

Role of the Cys90, Cys95 and Cys173 residues in the structure and function of the human platelet-activating factor receptor.

Le Gouill C, Parent JL, Rola-Pleszczynski M, Stanková J.

FEBS Lett. 1997 Feb 3;402(2-3):203-8.

20.

The role of conserved extracellular cysteine residues in vasopressin V2 receptor function and properties of two naturally occurring mutant receptors with additional extracellular cysteine residues.

Schülein R, Zühlke K, Oksche A, Hermosilla R, Furkert J, Rosenthal W.

FEBS Lett. 2000 Jan 21;466(1):101-6. Erratum in: FEBS Lett 2000 May 4;473(1):124.

Supplemental Content

Support Center